Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of statins for the treatment of depression in patients with acute coronary syndrome
S W Kim, Kyung‐Yeol Bae, Jong-Min Kim, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 8, pp. e620-e620
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge, Allan H. Young, Anthony J. Cleare
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 1245-1262
Open Access | Times Cited: 320
Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials
Estela Salagre, Brisa S. Fernandes, Seetal Dodd, et al.
Journal of Affective Disorders (2016) Vol. 200, pp. 235-242
Closed Access | Times Cited: 112
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Sung‐Wan Kim, Hee‐Ju Kang, Min Jhon, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 109
Depression is a risk factor for incident coronary heart disease in women: An 18-year longitudinal study
Adrienne O’Neil, Aaron J. Fisher, Katherine J. Kibbey, et al.
Journal of Affective Disorders (2016) Vol. 196, pp. 117-124
Closed Access | Times Cited: 90
Comorbidities in the diseasome are more apparent than real: What Bayesian filtering reveals about the comorbidities of depression
Péter Marx, Péter Antal, Bence Bolgár, et al.
PLoS Computational Biology (2017) Vol. 13, Iss. 6, pp. e1005487-e1005487
Open Access | Times Cited: 70
New drug candidates for depression – a nationwide population‐based study
Lars Vedel Kessing, Helene C. W. Rytgaard, Thomas A. Gerds, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 139, Iss. 1, pp. 68-77
Open Access | Times Cited: 65
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Michael Berk, Mohammadreza Mohebbi, Olivia Dean, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 54
Biomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
Rebecca Strawbridge, Allan H. Young, Anthony J. Cleare
FOCUS The Journal of Lifelong Learning in Psychiatry (2018) Vol. 16, Iss. 2, pp. 194-209
Open Access | Times Cited: 58
Do statins have an effect on depressive symptoms? A systematic review and meta-analysis
Megha Sai Yatham, Kavya Sai Yatham, Arun Ravindran, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 55-63
Closed Access | Times Cited: 53
Putative neuroprotective pharmacotherapies to target the staged progression of mental illness
Oliver D’Arcy Robertson, Nieves G. Coronado, Rickinder Sethi, et al.
Early Intervention in Psychiatry (2019) Vol. 13, Iss. 5, pp. 1032-1049
Open Access | Times Cited: 43
Statins in the treatment of depression: Hype or hope?
Ole Köhler‐Forsberg, Christian Otte, Stefan M. Gold, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107625-107625
Closed Access | Times Cited: 40
Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Alice M. G. Quinton, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 37
Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study
Jahad Alghamdi, Sabine Matou‐Nasri, Faisal Alghamdi, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 12, pp. 1067-1075
Open Access | Times Cited: 37
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Adam J. Walker, Yesul Kim, Igor Borissiouk, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 693-708
Closed Access | Times Cited: 25
Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression
Ioana-Alexandra Dogaru, Maria Gabriela Puiu, Mirela Manea, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1403-1403
Open Access | Times Cited: 16
Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome
Sung‐Wan Kim, Hee‐Ju Kang, Kyung‐Yeol Bae, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 80, pp. 250-254
Closed Access | Times Cited: 32
Update on Statin Treatment in Patients with Neuropsychiatric Disorders
Razieh Avan, Adeleh Sahebnasagh, Javad Hashemi, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1365-1365
Open Access | Times Cited: 22
Do Statins Have Antidepressant Effects?
Ole Köhler‐Forsberg, Christiane Gasse, Michael Berk, et al.
CNS Drugs (2017) Vol. 31, Iss. 5, pp. 335-343
Closed Access | Times Cited: 27
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Theodora A. Manolis, Antonis A. Manolis, Antonis S. Manolis
Angiology (2018) Vol. 70, Iss. 2, pp. 103-129
Closed Access | Times Cited: 25
New drug candidates for bipolar disorder—A nation‐wide population‐based study
Lars Vedel Kessing, Helene C. W. Rytgaard, Thomas A. Gerds, et al.
Bipolar Disorders (2019) Vol. 21, Iss. 5, pp. 410-418
Open Access | Times Cited: 25
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Brett D. M. Jones, Salman Farooqui, Stefan Kloiber, et al.
Life (2021) Vol. 11, Iss. 8, pp. 819-819
Open Access | Times Cited: 20
Plasma sphingolipids and depressive symptoms in coronary artery disease
Adam Dinoff, Mahwesh Saleem, Nathan Herrmann, et al.
Brain and Behavior (2017) Vol. 7, Iss. 11
Open Access | Times Cited: 24
Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic Strategies
Jian Xia, Meiling Chen, Heng Shao, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 356-356
Open Access | Times Cited: 6
Effects of various statins on depressive symptoms: A network meta-analysis
Ming‐Chia Lee, Tzu‐Rong Peng, Bi-Li Chen, et al.
Journal of Affective Disorders (2021) Vol. 293, pp. 205-213
Closed Access | Times Cited: 14
Effects of Simvastatin Beyond Dyslipidemia: Exploring Its Antinociceptive Action in an Animal Model of Complex Regional Pain Syndrome-Type I
Graziela Vieira, Juliana Cavalli, Elaine Cristina Dalazen Gonçalves, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top